Cargando…
Pharmacokinetic Exposures Associated With Oral Administration of Sorafenib in Dogs With Spontaneous Tumors
Sorafenib is a multi-kinase small molecule inhibitor that targets serine/threonine and tyrosine kinases including the RAF kinase family, VEGFR-2, and PDGFR. The aim of this study was to evaluate the systemic pharmacokinetics of a previously defined tolerable oral dose of sorafenib in tumor-bearing d...
Autores principales: | Cawley, Jacob R., Stewart, Samuel D., Mochel, Jonathan Paul, Veluvolu, Sridhar, Khanna, Chand, Fenger, Joelle M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9162170/ https://www.ncbi.nlm.nih.gov/pubmed/35664857 http://dx.doi.org/10.3389/fvets.2022.888483 |
Ejemplares similares
-
Tear Film Pharmacokinetics and Systemic Absorption Following Topical Administration of 1% Prednisolone Acetate Ophthalmic Suspension in Dogs
por: Sebbag, Lionel, et al.
Publicado: (2020) -
Pharmacokinetics of Oral Prednisone at Various Doses in Dogs: Preliminary Findings Using a Naïve Pooled-Data Approach
por: Sebbag, Lionel, et al.
Publicado: (2020) -
Pharmacokinetics of cannabidiol following single oral and oral transmucosal administration in dogs
por: della Rocca, Giorgia, et al.
Publicado: (2023) -
Pharmacokinetics of Cannabidiol Following Intranasal, Intrarectal, and Oral Administration in Healthy Dogs
por: Polidoro, Dakir, et al.
Publicado: (2022) -
Tolerability of oral sorafenib in pet dogs with a diagnosis of cancer
por: Foskett, Amanda, et al.
Publicado: (2017)